These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36870273)
1. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli. Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273 [TBL] [Abstract][Full Text] [Related]
2. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli. Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651 [TBL] [Abstract][Full Text] [Related]
3. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases. Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166 [TBL] [Abstract][Full Text] [Related]
4. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria. Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785 [TBL] [Abstract][Full Text] [Related]
5. Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive Wang Y; Sun X; Kong F; Xia L; Deng X; Wang D; Wang J Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32213926 [TBL] [Abstract][Full Text] [Related]
6. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial. Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802 [TBL] [Abstract][Full Text] [Related]
7. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1). Ge Y; Kang PW; Li JQ; Gao H; Zhai L; Sun LY; Chen C; Yang KW J Antibiot (Tokyo); 2021 Sep; 74(9):574-579. PubMed ID: 34234284 [TBL] [Abstract][Full Text] [Related]
8. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose. Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072 [TBL] [Abstract][Full Text] [Related]
9. H Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873 [TBL] [Abstract][Full Text] [Related]
10. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763 [TBL] [Abstract][Full Text] [Related]
11. Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1. Jackson AC; Pinter TBJ; Talley DC; Baker-Agha A; Patel D; Smith PJ; Franz KJ ChemMedChem; 2021 Feb; 16(4):654-661. PubMed ID: 33211374 [TBL] [Abstract][Full Text] [Related]
12. Discovery of isatin-β-methyldithiocarbazate derivatives as New Delhi metallo- β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates. Lv H; Zhu Z; Qian C; Li T; Han Z; Zhang W; Si X; Wang J; Deng X; Li L; Fang T; Xia J; Wu S; Zhou Y Biomed Pharmacother; 2023 Oct; 166():115439. PubMed ID: 37673020 [TBL] [Abstract][Full Text] [Related]
13. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors. Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326 [TBL] [Abstract][Full Text] [Related]
14. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance. Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y mBio; 2020 Mar; 11(2):. PubMed ID: 32184250 [TBL] [Abstract][Full Text] [Related]
16. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1). Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567 [TBL] [Abstract][Full Text] [Related]
17. Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1). Shen B; Yu Y; Chen H; Cao X; Lao X; Fang Y; Shi Y; Chen J; Zheng H PLoS One; 2013; 8(5):e62955. PubMed ID: 23675445 [TBL] [Abstract][Full Text] [Related]
18. A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc. Jackson AC; Zaengle-Barone JM; Puccio EA; Franz KJ ACS Infect Dis; 2020 May; 6(5):1264-1272. PubMed ID: 32298084 [TBL] [Abstract][Full Text] [Related]
19. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach. Muteeb G; Alsultan A; Farhan M; Aatif M Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073 [TBL] [Abstract][Full Text] [Related]
20. Systematic research of H Cui DY; Yang Y; Bai MM; Han JX; Wang CC; Kong HT; Shen BY; Yan DC; Xiao CL; Liu YS; Zhang E Bioorg Chem; 2020 Aug; 101():103965. PubMed ID: 32485471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]